The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome

Dawson, AJ, Sathyapalan, T, Vince, R et al. (4 more authors) (2019) The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome. Frontiers in Endocrinology, 10. 189. ISSN 1664-2392

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 Dawson, Sathyapalan, Vince, Coady, Ajjan, Kilpatrick and Atkin. This is an open access article under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/)
Keywords: polycystic ovary syndrome; exenatide; cardiovascular risk; endothelial function; inflammation; blood clot function; GLP-1 receptor agonists
Dates:
  • Published: 2 April 2019
  • Accepted: 6 March 2019
  • Published (online): 2 April 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM) > Clinical & Population Science Dept (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 17 Feb 2020 11:30
Last Modified: 17 Feb 2020 11:30
Status: Published
Publisher: Frontiers Media
Identification Number: https://doi.org/10.3389/fendo.2019.00189

Download

Share / Export

Statistics